close
Add to watchlist
Stereotaxis Inc (STXS) Healthcare, Medical Equipment & Supplies
Stereotaxis, Inc. designs, manufactures, and markets cardiology instrument control system for use in hospital's interventional surgical suite or interventional lab to treat arrhythmias and coronary artery disease in the United States, Canada, Europe, and internationally. The company offers Niobe system, which comprises Niobe Magnetic Navigation System that navigates catheters, guidewires, and other delivery devices through the blood vessels and chambers of the heart to treatment sites; Navigant, an advanced user interface or physician control center, which helps physicians to visualize and track procedures and to provide instrument control commands that govern the motion of the working tip of the catheter, guidewire, or other interventional device; and Cardiodrive, an automated catheter advancement system, which is used to remotely advance and retract the catheter in the patient's heart. The company also offers Odyssey Total Information Solution, which consolidates the multiple sources of diagnostic and imaging information found in the interventional lab into a large-screen user interface with single mouse control that can be connected via a private network line to other interventional labs or to a remote clinical call center. The company also markets and sells various disposable interventional devices, including catheters, guidewires, and other delivery devices. Stereotaxis markets its products through direct sales force, distributors, and sales agents. It has strategic partnership with Siemens AG Medical Solutions, Philips Medical Systems, and Biosense Webster, Inc. The company was founded in 1990 and is based in St. Louis, Missouri.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 0.70 |
| Volume | 113283 |
| Volume Avg | 216351 |
| 52 Week High | 4.24 |
| 52 Week Low | 0.68 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.58 |
| EPS change Q/Q | -240% |
| EPS change Q/Q Yr ago | 0% |
| EPS change Q/Q next Q est | -70% |
| EPS change Y/Y | -57.5% |
| REV change Q/Q | -29.66% |
| REV change Q/Q Yr ago | -3.77% |
| EPS next Q est | -0.10 |
| EPS next Y est | -0.35 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |